4.0 Article

In Patients with HIV-Infection, Chromium Supplementation Improves Insulin Resistance and Other Metabolic Abnormalities: A Randomized, Double-Blind, Placebo Controlled Trial

期刊

CURRENT HIV RESEARCH
卷 8, 期 2, 页码 113-120

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/157016210790442687

关键词

Insulin resistance; chromium; HIV; glucose; body fat redistribution; body composition

资金

  1. Canadian Foundation for AIDS Research
  2. German Research Foundation (DFG) [AR 497/1-1]

向作者/读者索取更多资源

Chromium is an essential micronutrient; chromium deficiency has been reported to cause insulin resistance, hyperglycemia and hyperlipidemia. The aim was to investigate the effect of chromium supplementation on insulin-resistance, other metabolic abnormalities, and body composition in people living with HIV. This was a randomized, double-blind, placebo-controlled trial. Fifty-two HIV-positive subjects with elevated glucose, lipids, or evidence of body fat redistribution, and who had insulin-resistance based on the calculation of homeostasis model of assessment (HOMA-IR >= 2.5) were assessed. Subjects who were on insulin or hypoglycemic medications were excluded. Subjects were randomized to receive either 400 ug/day chromium-nicotinate or placebo for 16 weeks. Forty-six subjects, 23 in each group, completed the study. Fasting blood insulin, glucose, lipid profile and body composition were measured before and after intervention. Chromium was tolerated without side effects and resulted in a significant decrease in HOMA-IR (median (IQR) (pre: 4.09 (3.02-8.79); post: 3.66 (2.40-5.46), p = 0.004), insulin (pre: 102 (85-226); post: 99 (59-131) pmol/L, p = 0.003), triglycerides, total body fat mass (mean +/- SEM) (pre: 17.3 +/- 1.7; post: 16.3 +/- 1.7 kg; p = 0.002) and trunk fat mass (pre: 23.8 +/- 1.9; post: 22.7 +/- 2.0%; p = 0.008). Blood glucose, C-peptide, total, HDL and LDL cholesterol, and hemoglobin A1c remained unchanged. Biochemical parameters did not change in the placebo group except for LDL cholesterol which increased significantly. Body weight and medication profile remained stable throughout the study for both groups. In summary, chromium improved insulin resistance, metabolic abnormalities, and body composition in HIV+ patients. This suggests that chromium supplements alleviate some of the antiretroviral-associated metabolic abnormalities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据